The V617F JAK 2 mutation is not a frequent event in patients with cerebral venous thrombosis without overt chronic myeloproliferative disorder

Thromb Haemost. 2008 Jun;99(6):1119-20. doi: 10.1160/TH08-02-0081.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Chronic Disease
  • Female
  • Gene Frequency
  • Genetic Predisposition to Disease
  • Humans
  • Intracranial Thrombosis / enzymology
  • Intracranial Thrombosis / genetics*
  • Janus Kinase 2 / genetics*
  • Male
  • Middle Aged
  • Mutation*
  • Myeloproliferative Disorders / enzymology
  • Myeloproliferative Disorders / genetics
  • Risk Factors
  • Venous Thrombosis / enzymology
  • Venous Thrombosis / genetics*

Substances

  • JAK2 protein, human
  • Janus Kinase 2